Surviving Blood Loss
Award Notice Posted
- Solicitation number
- W911QY-15-R-0023
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Awarded
- to University Of Alabama At Birmingham
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- W911QY15C0134 Federal contract award
- NAICS code
- Not on record
- PSC
- Not on record
- Place of performance
- ACC-APG - Natick (SPS) Attn: Amsrd-ACC-N, Natick Contracting Division (R and BaseOPS), Building 1, Kansas Street Natick MA 01760 US
Notice details come from SAM.gov. Updated .
Notice text
The U.S. Army Contracting Command - Aberdeen Proving Ground, Natick Contracting Division (ACC-APG-NCD), has a requirement on behalf of the Defense Health Program Joint Program Committee Six (JPC-6).
This acquisition will provide full solution clinical research support to guide EE-3-SO4 through FDA IND submission and GCP compliant Phase 1 and 2a clinical trials for an indication as a viable infusion therapy for the treatment of critical patients with significant blood loss. Support may also be required to conduct additional preclinical work as required to facilitate either the Phase 1 or Phase 2a clinical trials.
The NAICS code for this requirement is 541712. This acquisition will be conducted on a full and open basis and will be awarded based on a best value - tradeoff determination. A cost plus fixed fee contract is anticipated. The Request for Proposal (RFP) is anticipated to be posted on or around Wednesday, 29 April 2015, to FedBizOps. Proposals will be due 30 days after release of the RFP. Firms will not be reimbursed for any costs associated with proposal preparation. Questions may be addressed by email to Matthew Buchanan at matthew.r.buchanan6.civ@mail.mil.
Files
| File | Type | Posted |
|---|---|---|
| Attachment0002.pdf | ||
| W911QY-15-R-0023-0001.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity